Summary
Elevance Health, Inc. (formerly WellPoint, Inc.) filed an 8-K on September 17, 2013, to report the election of two new independent directors to its Board: John H. Short and Elizabeth E. Tallett. Their appointments are effective September 18, 2013, and October 1, 2013, respectively, with terms extending to the 2015 and 2016 Annual Shareholder Meetings. This move suggests a focus on strengthening board expertise and governance. Mr. Short, aged 69, has been appointed to the Audit and Strategic Innovation Committees. Ms. Tallett, aged 64, will serve on the Compensation and Governance Committees. Both directors will receive compensation as per the company's established director compensation program. The filing confirms no related-party transactions or arrangements requiring further disclosure for these new directors, indicating they are independent additions aimed at enhancing the board's oversight capabilities.
Key Highlights
- 1Appointment of two new independent directors: John H. Short and Elizabeth E. Tallett.
- 2Mr. Short's appointment is effective September 18, 2013, and Ms. Tallett's is effective October 1, 2013.
- 3Mr. Short will serve on the Audit and Strategic Innovation Committees.
- 4Ms. Tallett will serve on the Compensation and Governance Committees.
- 5Both directors will participate in the company's standard director compensation program.
- 6The company confirmed no disclosable relationships or arrangements for the new directors under Regulation S-K.
- 7The filing signifies an effort to enhance board composition and corporate governance.